XT-150: Clinical Trials

3 trials of XT-150, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Withdrawn 1
Phase 11Withdrawn 1

Follow XT-150: new trials by email Literature Review of XT-150 trials Research Report on XT-150

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of XT-150 for Facet Joint Osteoarthritis Pain
XT-150, Placebo - Facet Joint Pain, Back Pain
Phase 2CompletedXalud Therapeutics, Inc.752022-02-242025-01-15
Preliminary Safety and Efficacy of XT-150 in Facet Joint Osteoarthritis
XT-150 - Osteoarthritis, Spine
Phase 1 / Phase 2WithdrawnXalud Therapeutics, Inc.2021-10-012022-03-17
Efficacy and Safety of XT-150 in Osteoarthritis of the Knee
XT-150, Placebo - Osteoarthritis, Knee
Phase 2CompletedXalud Therapeutics, Inc.2892020-02-142025-03-27

Conditions studied

Inflammation (2)  ·  Back Pain (1)  ·  Osteoarthritis (1)  ·  Osteoarthritis, Knee (1)  ·  Osteoarthritis, Spine (1)  ·  Pain (1)

Sponsors

Xalud Therapeutics, Inc. (3)

Countries

Australia (2)  ·  United States (2)

Top investigators

Howard Rutman, MD (1)  ·  Morgan Stokes (1)

Results publications

PMID 40826764